S-Methyl 3-((2-hydroxyphenyl)methyl)dithiocarbazate (H(2)L(1)) and its bromo derivative (H(2)L(2)), which are traditionally biprotic tridentate (ONS) ligands, behave in an unprecedented manner when allowed to react with [VO(acac)(2)] under an oxidative environment in acetonitrile-water medium containing a catalytic amount of alkali metal ion. The products obtained are oxovanadium(V) compounds [VOL(L(cyclic))] (L = L(1), 1a, and L(2), 1b) that contain one molecule of ligand which undergoes metal-induced cyclization to form a thiadiazole ring. Compound 1a crystallizes in the triclinic space group P(-)1 with a = 9.1830(9) A, b = 9.4165(12) A, c = 12.700(2) A, alpha = 100.988(8)(o), beta = 100.195(7)(o), gamma = 78.774(8)(o), V = 1046.3(2) A(3), and Z = 2. With cobalt(III), however, the products [CoL(HL)].H(2)O (L = L(1), 2a, and L(2), 2b) have hydrogen-bonded dimeric structures with each ligand virtually carrying 1.5 units of negative charge as confirmed by X-ray crystal structure analysis of 2a. It also crystallizes in triclinic space group P(-)1 with a = 12.0842(8) A, b = 13.5251(9) A, c = 14.1960(10) A, alpha = 78.122(6)(o), beta = 73.888(6)(o), gamma = 78.255(6)(o), V = 2154.7(3) A(3), and Z = 4. In solution, 2a is a symmetric molecule as indicated by (1)H NMR, involving a characteristic hydrogen-bonded O-H-O broad feature in the downfield (at 14.5 ppm) connecting both monoprotonated (LH(-)) and deprotonated (L(2-)) forms of the ligand--a situation somewhat analogous to the classic H-F-H case as observed in bifluoride ion.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ic0200895 | DOI Listing |
ACS Med Chem Lett
January 2025
Department of Pharmaceutical Chemistry, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, Maharashtra 425405, India.
Linezolid, a widely used oxazolidinone antibiotic, exhibits potent activity against resistant bacterial infections but is associated with serotonergic toxicity, primarily due to its inhibition of monoamine oxidase (MAO). MAOs, consisting of MAO-A and MAO-B isoforms, play crucial roles in neurotransmitter metabolism, with implications for neurodegenerative disorders like Parkinson's and Alzheimer's diseases. This study aims to optimize Linezolid's structure to transform it into a selective MAO-B inhibitor.
View Article and Find Full Text PDFMolecules
January 2025
Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
MDM2 and MDM4 are major negative regulators of tumor suppressor p53. Beyond regulating p53, MDM2 possesses p53-independent activity in promoting cell cycle progression and tumorigenesis via its RING domain ubiquitin E3 ligase activity. MDM2 and MDM4 form heterodimer polyubiquitin E3 ligases via their RING domain interaction.
View Article and Find Full Text PDFSmall
January 2025
The Department of Medical Imaging, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Xingangzhong Road 466, Guangzhou, 518037, P. R. China.
The self-assembly of hydrophobic organic phototherapeutic agents (OPTAs) with expansive planar structures into nanoparticles (NPs) represents a pivotal strategy to bolster their biocompatibility. However, the tight molecular packing within these NPs significantly influences the generation of reactive oxygen species (ROS) and the photothermal conversion efficiency (PCE), posing a substantial hurdle to elevating the efficacy of photodynamic therapy (PDT) and photothermal therapy (PTT) for such NPs. In this article, three OPTAs by donor engineering are synthesized.
View Article and Find Full Text PDFFuture Med Chem
January 2025
Chemistry Department, Faculty of science(Girls), Al-Azhar University, Nasr City, Cairo, Egypt.
Aim: Emerging resistance among pathogens necessitates the development of novel antimicrobial agents. As a result, we aimed to synthesize new coumarins and study their antimicrobial activity with the hope of obtaining effective drugs.
Method: A series of coumarins were synthesized, characterized, and assessed for antimicrobial activity using broth microdilution and agar diffusion methods against Gram-positive (), Gram-negative () bacteria, and fungi ().
Objectives: To assess the efficacy and safety of the non-hormonal, neurokinin 3 receptor antagonist, fezolinetant, to treat moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy.
Design: Phase 3b randomised controlled trial.
Setting: 16 countries.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!